Back to Search Start Over

Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients

Authors :
Emma Ahlén Bergman
Ciputra Adijaya Hartana
Markus Johansson
Ludvig B. Linton
Sofia Berglund
Martin Hyllienmark
Christian Lundgren
Benny Holmström
Karin Palmqvist
Johan Hansson
Farhood Alamdari
Ylva Huge
Firas Aljabery
Katrine Riklund
Malin E. Winerdal
David Krantz
A. Ali Zirakzadeh
Per Marits
Louise K. Sjöholm
Amir Sherif
Ola Winqvist
Source :
Clinical Epigenetics, Vol 10, Iss 1, Pp 1-15 (2018)
Publication Year :
2018
Publisher :
BMC, 2018.

Abstract

Abstract Background Urinary bladder cancer is a common malignancy worldwide. Environmental factors and chronic inflammation are correlated with the disease risk. Diagnosis is performed by transurethral resection of the bladder, and patients with muscle invasive disease preferably proceed to radical cystectomy, with or without neoadjuvant chemotherapy. The anti-tumour immune responses, known to be initiated in the tumour and draining lymph nodes, may play a major role in future treatment strategies. Thus, increasing the knowledge of tumour-associated immunological processes is important. Activated CD4+ T cells differentiate into four main separate lineages: Th1, Th2, Th17 and Treg, and they are recognized by their effector molecules IFN-γ, IL-13, IL-17A, and the transcription factor Foxp3, respectively. We have previously demonstrated signature CpG sites predictive for lineage commitment of these four major CD4+ T cell lineages. Here, we investigate the lineage commitment specifically in tumour, lymph nodes and blood and relate them to the disease stage and response to neoadjuvant chemotherapy. Results Blood, tumour and regional lymph nodes were obtained from patients at time of transurethral resection of the bladder and at radical cystectomy. Tumour-infiltrating CD4+ lymphocytes were significantly hypomethylated in all four investigated lineage loci compared to CD4+ lymphocytes in lymph nodes and blood (lymph nodes vs tumour-infiltrating lymphocytes: IFNG -4229 bp p 0.05). Examination of individual lymph nodes displayed different methylation signatures, suggesting possible correlation with future survival. More advanced post-cystectomy tumour stages correlated significantly with increased methylation at the IFNG -4229 bp locus. Patients with complete response to neoadjuvant chemotherapy displayed significant hypomethylation in CD4+ T cells for all four investigated loci, most prominently in IFNG p

Details

Language :
English
ISSN :
18687075 and 18687083
Volume :
10
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Clinical Epigenetics
Publication Type :
Academic Journal
Accession number :
edsdoj.f5be49a7cd8479e9c1a1d7f1ba629ff
Document Type :
article
Full Text :
https://doi.org/10.1186/s13148-018-0536-6